# Lerming Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lerming-pharma

- Industry: Biotechnology
- Headquarters: Suzhou, China
- Website: www.lindmik.com
- Total disclosed funding: $14M
- Latest round: Series B (Jun 7, 2024)
- Investors on record: 6

## About

Established in 2019 and based in Suzhou, China, Lerming Pharma is a pharmacy company that focuses on the research and development, production and sales of innovative pharmaceutical preparations. The company headquarters is located in Suzhou, with a research and development center in Beijing, and business development departments in the United States and Japan which are responsible for the introduction of overseas projects. It has a factory building of 15000 square meters. In April 2023, Lerming Pharma raised series A funding from new investors Fuho Capital, Guantian Capital, Realharmony Capital, and Suzhou Wuzhong Financial Holdings. In June 2024, the firm raised a series B funding for CNY 100 million.

The company engaged in the research and development and production of preparations in the transdermal field. It corporates with many North American biopharmaceutical companies and introduces preparation platforms. The company provides transdermal preparation products including gel patches, hot melt adhesives, and solvent adhesives.

The company’s revenue is generated by providing medicines.

The company will use the series B funding for the research and development, production and registration of innovative formulations, and will focus on accelerating the commercial production and market promotion of flurbiprofen gel patch and loxoprofen sodium gel patch.

## Funding rounds

- Series B, Jun 7, 2024, $14M — China International Capital Corporation, Fuho Capital, Realharmony Capital, Chengming Capital
- Series A, Apr 14, 2023 — Fuho Capital, Guantian Capital, Realharmony Capital, Suzhou Wuzhong Financial Holdings

## Investors

- Fuho Capital (https://capitalatlas.ai/funds/fuho-capital) — Series A, Series B
- Guantian Capital (https://capitalatlas.ai/funds/guantian-capital) — Series A
- Realharmony Capital (https://capitalatlas.ai/funds/realharmony-capital) — Series A, Series B
- Suzhou Wuzhong Financial Holdings — Series A
- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series B
- Chengming Capital — Series B